Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 ,inter alia, to consider and approve Audited Standalone & Consolidated Financial Results of the Company alongwith the Auditor Report as on March 31, 2025 & to transact other businesses with the permission of Chair.